Efficacy of Ginkgo biloba extract in amyloid PET-positive patients with mild cognitive impairment

Efficacy of Ginkgo biloba extract in amyloid PET-positive patients with mild cognitive impairment

BackgroundMild cognitive impairment (MCI) with amyloid PET positivity represents a prodromal stage of Alzheimer’s disease (AD), yet no disease-modifying therapies are currently approved. Ginkgo biloba, traditionally used in East Asian and European ethnomedicine as an oral decoction or standardized e...

Full description

Saved in:

Bibliographic Details
Main Authors:	YoungSoon Yang, Min-Seong Koo, Yong Tae Kwak
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Neurology
Subjects:	Ginkgo biloba mild cognitive impairment Alzheimer’s disease amyloid PET MDS-Oaβ
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1639924/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EFFICACY AND SAFETY OF GINKGO BILOBA IN ELDERLY PATIENTS WITH CONTROLLED ARTERIAL HYPERTENSION AND CIRCULATORY ENCEPHALOPATHY
by: V. V. Jakusevich, et al.
Published: (2016-01-01)

Environmentally biopreparation of selenium and zinc nanoparticles using Ginkgo biloba extract in preservation of edible oils
by: Ayman Y. El-Khateeb
Published: (2020-03-01)

Potential therapeutic effects of Ebixa, Ginkgo biloba, and selenium in a cadmium chloride-induced Alzheimer’s disease manifestations in rats
by: Afaf Alrikabi, et al.
Published: (2025-07-01)

Ginkgetin from Ginkgo biloba: mechanistic insights into anticancer efficacy
by: Bei Xiong, et al.
Published: (2025-08-01)

Estudio sobre los factores que impiden la putrefacción de la semilla carnosa de Ginkgo biloba L.
by: Juan B. Rossi, et al.

EVALUATION OF THE EFFECT OF FLAVONOID EXTRACT OF Ginkgo biloba LEAVES AND GLIMEPHAN ON OXIDATIVE STRESS AND RETINA DEGENERATION IN DIABETIC MALE RABBITS INDUCED BY STREPTOZOTOCIN
by: Wasan A. Jawad, et al.
Published: (2020-06-01)

Microscopical diagnostic elements of leaves of Ginkgo biloba L. and herbs of a Filipendula ulmaria (L.) Maxim . in the tablets «GINKGOTROPIL»
by: J. V. Daironas, et al.
Published: (2016-03-01)

Safety and efficacy of a feed additive consisting of a dry extract obtained from the leaves of Ginkgo biloba L. (ginkgo extract) for horses, dogs, cats, rabbits and guinea pigs (FEFANA asbl)
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2024-04-01)

Evaluating ginkgetin from Ginkgo biloba as a novel agent for sleep promotion through molecular docking and in vivostudies
by: Mir Behrad Aghazadeh Ghadim, et al.
Published: (2025-06-01)

Exploring the efficacy of nortriptyline, buspirone, and Ginkgo biloba extract as alternative medications in ADHD management: a systematic review
by: Ramin Abdi Dezfouli, et al.
Published: (2025-07-01)

Anti-Oral Microbial Effect of Ginkgo biloba Leaf Ethanol Extract: A Multi-Target Approach to Cariogenic and Periodontal Pathogens
by: Soon-Jeong Jeong
Published: (2025-06-01)

Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial
by: Amir Ahmadzadeh Amiri, et al.
Published: (2025-05-01)

Effect of High-Intensity Functional Training Protocol Combined with Ginkgo Biloba SuPPlementation on the Antioxidant Status of Male Firefighters in the OPerational Division of Yazd City
by: Hamid Sedaghat, et al.
Published: (2025-07-01)

Macroporous resin purification and quantification by LC-MS of bioactive flavonoids in Ginkgo biloba leaves
by: Kang Min, et al.
Published: (2025-12-01)

Protective effect of Ginkgo biloba and Olive oil on the reproductive performance of male albino rats exposed to oxidative stress induced by Potassium dichromate
by: Takea S. A.
Published: (2023-02-01)

Antioxidant Potential of Natural Extract of <i>Ginkgo biloba</i> L. in Relation to Chorioallantoic Membrane (CAM) Vessels of Chicken Embryo
by: Miriam Bačkorová, et al.
Published: (2025-05-01)

Response surface optimization reveals monthly total flavonoid peaks in Ginkgo biloba leaves with corresponding DPPH scavenging activity
by: Xiaoyu Shen, et al.
Published: (2025-05-01)

Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort
by: Yuhan Xie, et al.
Published: (2025-01-01)

Unraveling the Multilayered Regulatory Networks of miRNAs and PhasiRNAs in <i>Ginkgo biloba</i>
by: Qixuan Wei, et al.
Published: (2025-05-01)

Efficacy of ginkgo biloba extract in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis of randomized controlled trials
by: Xuxin Sun, et al.
Published: (2025-03-01)

Ginkgo biloba extract ameliorates skin fibrosis in a bleomycin-induced mouse model of systemic sclerosis
by: Beomgu Lee, et al.
Published: (2024-12-01)

Navigating the introduction of anti-amyloid therapy in Europe: a position statement by individual members of the EADC
by: Kristian S. Frederiksen, et al.
Published: (2025-05-01)

Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: A meta-analysis
by: Fatemeh Sedghi, et al.
Published: (2025-12-01)

DEVELOPMENT OF THE METHODS OF STANDARTIZATION DRY EXTRACT AND MEDICAL DRUGS GINKGO BILOBA
by: M. A. Marchenko, et al.
Published: (2017-08-01)

Faster decline of very prodromal dementia with Lewy bodies when amyloid positive
by: Frédéric Blanc, et al.
Published: (2025-04-01)

Metabolomic and transcriptomic analyses unveil the accumulation of shikimic acid in the leaves of Ginkgo biloba
by: Wanwen Yu, et al.
Published: (2025-08-01)

Predicting amyloid status in mild cognitive impairment: the role of semantic intrusions combined with plasma biomarkers
by: Yao Lu, et al.
Published: (2025-06-01)

The Efficacy of Anti-amyloid Monoclonal Antibodies in Early Alzheimer’s Dementia: A Systematic Review
by: Alyaa Mostafa, et al.
Published: (2025-05-01)

Perspective: Minimally clinically important “symptomatic” benefit associated with disease modification resulting from anti‐amyloid immunotherapy
by: John Alam, et al.
Published: (2025-01-01)

Cognitive impairment in young and middle-aged patients
by: E. G. Demianovskaya, et al.
Published: (2023-07-01)

METHOD DEVELOPMENT AND VALIDATION OF TOTAL FLAVONOIDS ASSAY IN TABLETS WITH NOOTROPIC ACTION
by: N. N. Krylov, et al.
Published: (2019-01-01)

The life style of glaucoma patients: a scientific rationale for basic recommendations
by: N. A. Bakunina, et al.
Published: (2022-09-01)

Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer&rsquo;s Disease Neuroimaging Initiative
by: Russo MJ, et al.
Published: (2016-09-01)

Computerized cognitive testing to capture cognitive decline in Alzheimer's disease: Longitudinal findings from the ARMADA study
by: Roos J. Jutten, et al.
Published: (2025-01-01)

CSF Amyloid-β42 associates with neuropsychiatric and cognitive outcomes via cerebral glucose metabolism
by: Ali Azargoonjahromi, et al.
Published: (2025-07-01)

Peculiarities of the postnatal physical development of the offspring of rats treated with aqueous plant extracts as an additional load
by: M. L. Temkin, et al.
Published: (2022-11-01)

Cognitive Effect of Levetiracetam in Patients with Alzheimer’s Disease or Mild Cognitive Impairment: A Systematic Review
by: Mohamad Hosein Mohamadi, MD, et al.
Published: (2025-01-01)

Editorial: Omics applications in agriculture systems: unveiling functionality and practicality
by: Dinesh Adhikary, et al.
Published: (2025-07-01)

The Link Between Physical Function, β-Amyloid, and Cognitive Aging in Women
by: Raquel Pedrero-Chamizo, et al.
Published: (2025-05-01)

Lead-induced hypertension and cognitive dysfunction: brain amyloid pathology
by: Yunbo Zhang, et al.
Published: (2025-08-01)